Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

about

Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.

P2860

Q36426504-56819A37-0949-41F7-B7D9-1E138885ECB8

P2860

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

Item

http://www.wikidata.org/entity/Q42559398

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@en

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@nl

type

Item

label

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@en

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@nl

prefLabel

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@en

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@nl

P1476

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

@en

P2093

Aninda Basu

http://www.w3.org/2001/XMLSchema#string

Pallavi Banerjee

http://www.w3.org/2001/XMLSchema#string

Soumitro Pal

http://www.w3.org/2001/XMLSchema#string

P2860

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40

Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development

Prevention of cancer by inhibiting aging.

Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells

Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin

P304

633-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4161/CC.11.4.19276

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221794741

http://www.w3.org/2001/XMLSchema#string

P698

22293493

http://www.w3.org/2001/XMLSchema#string

P932

3318099

http://www.w3.org/2001/XMLSchema#string

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

about

P2860

P2860

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932